Radiopharm Theranostics Files 6-K Report
Ticker: RDPTF · Form: 6-K · Filed: Jun 24, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, disclosure
TL;DR
Radiopharm Theranostics filed a 6-K, standard foreign issuer report.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on June 24, 2025, reporting information for the month of June 2025. The company, incorporated in Australia, is in the pharmaceutical preparations industry and has its principal executive offices in Carlton South, Victoria. This filing indicates they are furnishing information to the SEC as a foreign private issuer.
Why It Matters
This filing provides routine disclosure for foreign private issuers, offering insights into the company's ongoing reporting obligations and operational status.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would indicate elevated risk.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — SEC File Number
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- 62 Lygon Street, Carlton South, Victoria, 3053, Australia (company) — Principal executive office address
FAQ
What type of SEC filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the registrant filing this report?
The registrant is Radiopharm Theranostics Limited.
What is the Commission File Number for this registrant?
The Commission File Number is 001-41621.
Where are Radiopharm Theranostics Limited's principal executive offices located?
The principal executive offices are located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Does Radiopharm Theranostics Limited file annual reports under Form 20-F or Form 40-F?
Radiopharm Theranostics Limited indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 24, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).